COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
AURI Token Listing and Partnership With a Top 100 CoinMarketcap Exchange
Auri Inc. announces partnership and listing of AURI Token on Salavi Exchange, providing increased market exposure. Salavi Exchange offers a variety of cryptocurrencies, security measures, user-friendly interface, high liquidity, and mobile accessibility -
COMMUNIQUÉ DE PRESSE
Sales at prior-year level with decline in market momentum
-
-
COMMUNIQUÉ DE PRESSE
Ginkgo Mortgage Investment Corporation's AGM Highlights Stellar 2023 Performance and Growth Initiatives
Ginkgo MIC successfully convened its 2024 Annual General Meeting in Toronto, revealing substantial achievements including portfolio growth and robust retained earnings. CEO expresses gratitude for investors' trust and highlights the company's commitment to reliable and profitable investment opportunities -
-
COMMUNIQUÉ DE PRESSE
UN Global Compact Network Bolivia welcomes BLUEGRACE ENERGY BOLIVIA, the Country's Largest Corporate Sustainability Initiative.
BlueGrace Energy Bolivia (BGEB) joins the UN Global Compact Network Bolivia to support Sustainable Development Goals. Collaborates with APRISCO ENERGY INDUSTRIES S.L. and MAXIMANCE 2030 LTD for environmental sustainability projects. Initiatives include carbon credit issuance and Amazon Rainforest Conservation -
COMMUNIQUÉ DE PRESSE
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important Deadline in Securities Class Action - EVVTY
Rosen Law Firm announces class action lawsuit on behalf of Evolution AB (publ) investors for securities class action. Investors may be entitled to compensation and are encouraged to secure qualified counsel. Details of the case include misleading statements affecting Evolution's revenue and growth -
COMMUNIQUÉ DE PRESSE
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
Rosen Law Firm reminds Eagle Pharmaceuticals, Inc. investors of lead plaintiff deadline in securities class action. Investors may be entitled to compensation. Join the class action at https://rosenlegal.com/submit-form/?case_id=20722 or call 866-767-3653 for information -
COMMUNIQUÉ DE PRESSE
ROSEN, A LEADING LAW FIRM, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important February 2 Deadline in Securities Class Action First Filed by the Firm - EH
Rosen Law Firm, a global investor rights law firm, reminds EHang Holdings Limited investors of important February 2, 2024 lead plaintiff deadline in securities class action against the company
